Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07304934
Eligibility Criteria:
Inclusion Criteria:
1. Patients aged 18 to 70;
2. Direct Surgery Group (Cohort 1) : Radical surgery was performed without neoadjuvant therapy;
3. Neoadjuvant therapy group (Cohort 2) : The initial diagnosis was invasive breast cancer with confirmed axillary lymph node metastasis, and the patient was willing to undergo radical surgery at the end of treatment;
4. Plasma from patients during treatment can be obtained;
5. Be willing to sign the informed consent form. -
Exclusion Criteria:
1. Be pregnant or breastfeeding;
2. Patients whose lesions have been resected;
3. Suffered from other types of malignant tumors with a clear pathological diagnosis within 5 years prior to enrollment;
4. Within the past year of enrollment, the patient had other malignant tumors suspected by imaging, but they were not confirmed by pathology;
5. Suspected distant metastatic lesions on imaging, or potential lymph node lesions that cannot be completely cured by surgery;
6. Have received any blood product infusion treatment in the past 30 days. -
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT07304934
Study Brief:
Protocol Section:
NCT07304934